74 related articles for article (PubMed ID: 16289480)
1. Structural-activity relationship study on C-4 carbon atom of the CB1 antagonist SR141716: synthesis and pharmacological evaluation of 1,2,4-triazole-3-carboxamides.
Jagerovic N; Hernandez-Folgado L; Alkorta I; Goya P; Martín MI; Dannert MT; Alsasua A; Frigola J; Cuberes MR; Dordal A; Holenz J
Eur J Med Chem; 2006 Jan; 41(1):114-20. PubMed ID: 16289480
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of long-chain amide analogs of the cannabinoid CB1 receptor antagonist N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716) with unique binding selectivities and pharmacological activities.
Thomas BF; Francisco ME; Seltzman HH; Thomas JB; Fix SE; Schulz AK; Gilliam AF; Pertwee RG; Stevenson LA
Bioorg Med Chem; 2005 Sep; 13(18):5463-74. PubMed ID: 15994087
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationship of 1,2,4-triazole-containing diarylpyrazolyl carboxamide as CB1 cannabinoid receptor-ligand.
Seo HJ; Kim MJ; Lee SH; Lee SH; Jung ME; Kim MS; Ahn K; Kim J; Lee J
Bioorg Med Chem; 2010 Feb; 18(3):1149-62. PubMed ID: 20045337
[TBL] [Abstract][Full Text] [Related]
4. Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonists.
Lange JH; van Stuivenberg HH; Coolen HK; Adolfs TJ; McCreary AC; Keizer HG; Wals HC; Veerman W; Borst AJ; de Looff W; Verveer PC; Kruse CG
J Med Chem; 2005 Mar; 48(6):1823-38. PubMed ID: 15771428
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of novel 4-alkyl-5-thien-2'-yl pyrazole carboxamides.
Lazzari P; Pau A; Tambaro S; Asproni B; Ruiu S; Pinna G; Mastinu A; Curzu MM; Reali R; Bottazzi ME; Pinna GA; Murineddu G
Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):254-76. PubMed ID: 22931442
[TBL] [Abstract][Full Text] [Related]
6. Allosteric modulation of the cannabinoid CB1 receptor.
Price MR; Baillie GL; Thomas A; Stevenson LA; Easson M; Goodwin R; McLean A; McIntosh L; Goodwin G; Walker G; Westwood P; Marrs J; Thomson F; Cowley P; Christopoulos A; Pertwee RG; Ross RA
Mol Pharmacol; 2005 Nov; 68(5):1484-95. PubMed ID: 16113085
[TBL] [Abstract][Full Text] [Related]
7. Potent imidazole and triazole CB1 receptor antagonists related to SR141716.
Dyck B; Goodfellow VS; Phillips T; Grey J; Haddach M; Rowbottom M; Naeve GS; Brown B; Saunders J
Bioorg Med Chem Lett; 2004 Mar; 14(5):1151-4. PubMed ID: 14980654
[TBL] [Abstract][Full Text] [Related]
8. Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide.
Murineddu G; Ruiu S; Loriga G; Manca I; Lazzari P; Reali R; Pani L; Toma L; Pinna GA
J Med Chem; 2005 Nov; 48(23):7351-62. PubMed ID: 16279795
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB1 receptor.
Chen RZ; Frassetto A; Lao JZ; Huang RR; Xiao JC; Clements MJ; Walsh TF; Hale JJ; Wang J; Tong X; Fong TM
Eur J Pharmacol; 2008 Apr; 584(2-3):338-42. PubMed ID: 18336811
[TBL] [Abstract][Full Text] [Related]
10. Oxadiazole-diarylpyrazole 4-carboxamides as cannabinoid CB1 receptor ligands.
Lee SH; Seo HJ; Kim MJ; Kang SY; Song KS; Lee SH; Jung ME; Kim J; Lee J
Bioorg Med Chem Lett; 2009 Apr; 19(7):1899-902. PubMed ID: 19269817
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterisation of the CB
Mazeh AC; Angus JA; Wright CE
Eur J Pharmacol; 2021 Oct; 909():174433. PubMed ID: 34416240
[TBL] [Abstract][Full Text] [Related]
12. SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization.
Rinaldi-Carmona M; Barth F; Congy C; Martinez S; Oustric D; Pério A; Poncelet M; Maruani J; Arnone M; Finance O; Soubrié P; Le Fur G
J Pharmacol Exp Ther; 2004 Sep; 310(3):905-14. PubMed ID: 15131245
[TBL] [Abstract][Full Text] [Related]
13. Further evidence for the presence of cannabinoid CB1 receptors in mouse vas deferens.
Pertwee RG; Joe-Adigwe G; Hawksworth GM
Eur J Pharmacol; 1996 Jan; 296(2):169-72. PubMed ID: 8838453
[TBL] [Abstract][Full Text] [Related]
14. Facile synthesis, ex-vivo and in vitro screening of 3-sulfonamide derivative of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid piperidin-1-ylamide (SR141716) a potent CB1 receptor antagonist.
Kumar Srivastava B; Soni R; Patel JZ; Jha S; Shedage SA; Gandhi N; Sairam KV; Pawar V; Sadhwani N; Mitra P; Jain MR; Patel PR
Bioorg Med Chem Lett; 2008 Jul; 18(14):3882-6. PubMed ID: 18585913
[TBL] [Abstract][Full Text] [Related]
15. Discovery of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1h-1,2,4-triazole, a novel in vivo cannabinoid antagonist containing a 1,2,4-triazole motif.
Jagerovic N; Hernandez-Folgado L; Alkorta I; Goya P; Navarro M; Serrano A; Rodriguez de Fonseca F; Dannert MT; Alsasua A; Suardiaz M; Pascual D; Martín MI
J Med Chem; 2004 May; 47(11):2939-42. PubMed ID: 15139773
[TBL] [Abstract][Full Text] [Related]
16. F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist.
Shen CP; Xiao JC; Armstrong H; Hagmann W; Fong TM
Eur J Pharmacol; 2006 Feb; 531(1-3):41-6. PubMed ID: 16438957
[TBL] [Abstract][Full Text] [Related]
17. Methoxy- and fluorine-substituted analogs of O-1302: synthesis and in vitro binding affinity for the CB1 cannabinoid receptor.
Tobiishi S; Sasada T; Nojiri Y; Yamamoto F; Mukai T; Ishiwata K; Maeda M
Chem Pharm Bull (Tokyo); 2007 Aug; 55(8):1213-7. PubMed ID: 17666847
[TBL] [Abstract][Full Text] [Related]
18. Tetrazole-biarylpyrazole derivatives as cannabinoid CB1 receptor antagonists.
Kang SY; Lee SH; Seo HJ; Jung ME; Ahn K; Kim J; Lee J
Bioorg Med Chem Lett; 2008 Apr; 18(7):2385-9. PubMed ID: 18337096
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists.
Lan R; Liu Q; Fan P; Lin S; Fernando SR; McCallion D; Pertwee R; Makriyannis A
J Med Chem; 1999 Feb; 42(4):769-76. PubMed ID: 10052983
[TBL] [Abstract][Full Text] [Related]
20. 1,2,3-Triazole derivatives as new cannabinoid CB1 receptor antagonists.
Hou DR; Alam S; Kuan TC; Ramanathan M; Lin TP; Hung MS
Bioorg Med Chem Lett; 2009 Feb; 19(3):1022-5. PubMed ID: 19095444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
